NUVL- Nuvalent, Inc.

Name: Nuvalent, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Shair Matthew	1.38M	$170.72M	-
CEO	Porter James Richard	324.9K	$40.11M	-
CFO	Balcom Alexandra	99.2K	$12.25M	-
Other	Noci Darlene	86.8K	$10.72M	-5,500
Other	Pelish Henry E.	83.4K	$10.30M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 28, 2026	Miller Deborah Ann	Chief Legal Officer	Sale+OE	5,500	$107.84	$593,100.52	-2.2%	-	-
May 28, 2026	Noci Darlene	Chief Development Officer	Sale+OE	5,500	$107.80	$592,923.04	-1.8%	-	-
Feb 26, 2026	Miller Deborah Ann	Chief Legal Officer	Sale+OE	5,500	$103.05	$566,787.54	-2.9%	+3.2%	-
Feb 26, 2026	Noci Darlene	Chief Development Officer	Sale+OE	5,500	$103.03	$566,682.00	-3.0%	+3.2%	-
Jan 6, 2026	Noci Darlene	Chief Development Officer	Sell	7,417	$97.25	$721,320.39	-2.4%	+6.7%	-
Jan 6, 2026	Miller Deborah Ann	Chief Legal Officer	Sell	6,952	$97.26	$676,157.59	-2.2%	+6.7%	-
Jan 6, 2026	Balcom Alexandra51	Chief Financial Officer	Sell	7,417	$97.25	$721,320.39	-1.2%	+6.7%	-
Jan 6, 2026	Porter James Richard47	President And CEO	Sell	27,433	$97.26	$2,668,259.95	-1.3%	+6.7%	-
Jan 6, 2026	Pelish Henry E.61	Chief Scientific Officer	Sell	5,160	$97.24	$501,752.89	-1.1%	+6.7%	-
Jan 6, 2026	Turner Christopher Durant	Chief Medical Officer	Sell	7,417	$97.25	$721,320.39	-1.8%	+6.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC